|
Originally published In Press as doi:10.1074/jbc.C500024200 on February 18, 2005
J. Biol. Chem., Vol. 280, Issue 14, 14288-14292, April 8, 2005
A Loss-of-Function Mutation in Natriuretic Peptide Receptor 2 (Npr2) Gene Is Responsible for Disproportionate Dwarfism in cn/cn Mouse*
Takehito Tsuji and
Tetsuo Kunieda
From the
Graduate School of Natural Science and Technology, Okayama University, 1-1-1, Tsushima-naka, Okayama 700-8530, Japan
The achondroplastic mouse is a spontaneous mutant characterized by disproportionate dwarfism with short limbs and tail due to disturbed chondrogenesis during endochondral ossification. These abnormal phenotypes are controlled by an autosomal recessive gene (cn). In this study, linkage analysis using 115 affected mice of F2 progeny mapped the cn locus on an 0.8-cM region of chromosome 4, and natriuretic peptide receptor 2 (Npr2) gene was identified as the most potent candidate for the cn mutant in this region. This gene encodes a receptor for C-type natriuretic peptide (CNP) that positively regulates longitudinal bone growth by producing cGMP in response to CNP binding to the extracellular domain. Sequence analyses of the Npr2 gene in cn/cn mice revealed a T to G transversion leading to the amino acid substitution of highly conserved Leu with Arg in the guanylyl cyclase domain. In cultured chondrocytes of cn/cn mice, stimulus with CNP did not significantly increase intracellular cGMP concentration, whereas it increased in +/+ mice. Transfection of the mutant Npr2 gene into COS-7 cells also showed similar results, indicating that the missense mutation of the Npr2 gene in cn/cn mice resulted in disruption of the guanylyl cyclase activity of the receptor. We therefore concluded that the dwarf phenotype of cn/cn mouse is caused by a loss-of-function mutation of the Npr2 gene, and cn/cn mouse will be a useful model to further study the molecular mechanism regulating endochondral ossification by CNP/natriuretic peptide receptor B signal.
Received for publication, January 19, 2005
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-86-251-8325; Fax: 81-86-251-8388; E-mail: takehito{at}cc.okayama-u.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Yasoda, H. Kitamura, T. Fujii, E. Kondo, N. Murao, M. Miura, N. Kanamoto, Y. Komatsu, H. Arai, and K. Nakao
Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal Dysplasias
Endocrinology,
July 1, 2009;
150(7):
3138 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Hume, J. Buttgereit, A. M. Al-Awadhi, S. S. Al-Suwaidi, A. John, M. Bader, M. C. Seabra, L. Al-Gazali, and B. R. Ali
Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux
Hum. Mol. Genet.,
January 15, 2009;
18(2):
267 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Moffatt, G. Thomas, K. Sellin, M.-C. Bessette, F. Lafreniere, O. Akhouayri, R. St-Arnaud, and C. Lanctot
Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth
J. Biol. Chem.,
December 14, 2007;
282(50):
36454 - 36462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schmidt, A. Stonkute, R. Juttner, S. Schaffer, J. Buttgereit, R. Feil, F. Hofmann, and F. G. Rathjen
The receptor guanylyl cyclase Npr2 is essential for sensory axon bifurcation within the spinal cord
J. Cell Biol.,
October 22, 2007;
179(2):
331 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hachiya, Y. Ohashi, Y. Kamei, T. Suganami, H. Mochizuki, N. Mitsui, M. Saitoh, M. Sakuragi, G. Nishimura, H. Ohashi, et al.
Intact Kinase Homology Domain of Natriuretic Peptide Receptor-B Is Essential for Skeletal Development
J. Clin. Endocrinol. Metab.,
October 1, 2007;
92(10):
4009 - 4014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sogawa, T. Tsuji, Y. Shinkai, K. Katayama, and T. Kunieda
Short-Limbed Dwarfism: slw Is a New Allele of Npr2 Causing Chondrodysplasia
J. Hered.,
September 1, 2007;
98(6):
575 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Langenickel, J. Buttgereit, I. Pagel-Langenickel, M. Lindner, J. Monti, K. Beuerlein, N. Al-Saadi, R. Plehm, E. Popova, J. Tank, et al.
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B
PNAS,
March 21, 2006;
103(12):
4735 - 4740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
Endocr. Rev.,
February 1, 2006;
27(1):
47 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Krejci, B. Masri, V. Fontaine, P. B. Mekikian, M. Weis, H. Prats, and W. R. Wilcox
Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis
J. Cell Sci.,
November 1, 2005;
118(21):
5089 - 5100.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|